Latest News

  • April 30, 2012

  • Horizon Discovery and H3 Biomedicine collaborate to identify and validate novel cancer targets

  • Horizon Discovery and H3 Biomedicine collaborate to identify and validate novel, patient-relevant cancer targets: H3 Biomedicine to employ Horizon’s unique gene editing technology and isogenic cell lines to validate genetically defined drug targets for development of cancer therapeutics.

  • Read Story

  • April 23, 2012

  • Horizon Discovery receives the Queen’s Award for Enterprise in International Trade

  • The UK’s most prestigious business award granted in recognition of outstanding achievement in export growth

  • Read Story

  • March 26, 2012

  • Horizon Partners with EMQN to Minimise Variability in Cancer Diagnostic Testing Across Europe

  • Horizon Partners with EMQN to Minimise Variability in Cancer Diagnostic Testing Across Europe | Genetically defined human genomic reference standards for cancer diagnostics proficiency testing schemes

  • Read Story

  • March 21, 2012

  • Horizon Discovery Named Business of the Year

  • Horizon Discovery Named Business of the Year - Business Weekly Awards 2012

  • Read Story

  • March 12, 2012

  • Horizon Discovery & Rosalind Franklin University to Develop Cystic Fibrosis Cellular Disease Models

  • Horizon Discovery & Rosalind Franklin University to Develop Cystic Fibrosis Cellular Disease Models - Isogenic cell lines to be generated using Horizon’s rAAV gene editing platform

  • Read Story